Papers: 10.7759/cureus.9812

https://doi.org/10.7759/cureus.9812

FDA Approved Biologics: Can Etanercept and Ustekinumab be Considered a First-Line Systemic Therapy for Pediatric/Adolescents in Moderate to Severe Psoriasis? A Systematic Review

Cited by: 3
Author(s): Nida Aslam, Hajra Saleem, Salikh Murtazaliev, Sohail Quazi, Safeera Khan
Published: about 6 years ago

Software Mentions 1